1. The document outlines the rules and structure of a breast cancer quiz with 4 rounds: a visual round, multiple choice round, clinical trial identification round, and true/false round. 2. The visual round involves identifying devices, images, and celebrities related to breast cancer. The multiple choice round contains questions about breast cancer criteria, definitions, and screening recommendations. 3. The clinical trial round tasks teams with naming clinical trials from descriptions of trial details. The true/false round presents statements about breast cancer topics like DCIS, male breast cancer, and Mammaprint to identify as true or false.

1. Breast cancer Quiz
Dr Bharti Devnani
Moderator--Dr Ritesh Kumar

2. Rules
4 rounds
1st –Visual round
2nd – Multiple choice questions round
3rd- Clinical trial round
4th – True/False round
At any point of time Dr Ritesh’s decision is final

3. Round 1-Visual round
3 questions for each team
+10, -5
Lifeline- Call ur SR -Once
Questions can be passed
Last question on a piece of paper by all teams

4. Identify the device and its use

5. Identify the device & use

6. Spot diagnosis

7. Nodal staging of the disease

8. CLD and %Pulmonary toxicity

9. Which quadrant the lesion is?

10. Identify the radiation field and
indication

11. Identify the planning technique

12. Identify the planning technique

13. SCORES

14. A CB
D
E
F

15. Plz don’t shout, Raise your hands

16. Celebrity with breast cancer

17. SCORES

18. Round 2- MCQ
2 Q/team
Can use 50-50 lifeline once
Mandatory to attempt after using lifeline
+10,+5,-5
Questions can not be passed

19. Which is a relative contraindication for BCS ?
1. Pregnancy
2. Diffuse suspicious or malignant appear
microcalcification
3. Prior history of RT
4. Diffusely positive pathologic margins

20. Criteria NOT included in Nottingham or Elston-
Ellis Bloom Richardson scoring is
1. Necrosis
2. Mitotic count
3. Tubule formation
4. Nuclear pleomorphism

21. • Definition of menopause- False statement is
1. FSH- 35mIU/ml,Estradiol- 5 pg/ml
2. Age>50 yrs
3. Age < 50 yrs but amenorrheic for 12 months
4. BSO

22. • A 50 yrs old lady with LABC underwent
NACT followed by MRM. Pathology showed
no response to chemotherapy. As per Miller-
Payne histopathological grading the tumor
response would be-
• Grade 1
• Grade 2
• Grade 3
• Grade 4

23. • Metastasis in a node of size >0.2 mm and >
200 cells
1. ITC
2. pN0 (i-)
3. pN1 mi
4. pN1a

24. Screening
Not an indication for annual MRI screening
1. BRCA mutation commence at age 25
2. First degree relative of BRCA commence at
25
3. > 20 percent lifetime risk by Gail model
4. Dense breast on mammography

25. Plz don’t shout, Raise your hands

26. Name the author

27. SCORES

28. Round 3
2 Q/team
Identify the trial
Lifeline-Double dip- 2 guesses at a question
(Only by primary team once)
Can pass
+10 , +5,-5 to primary team, +5,-5 for
subsequent teams

29. Name the trial

30. Name the trial

31. Name the trial

32. Mastectomy + Axillary Procedure
• T1 N1
• T2 N0 (Gr 3/ LVI)
• T2 N1
• T3 N0
Chest wall RT No Chest wall RT

33. Name the trial

34. Name the trial

35. Plz don’t shout, Raise your hands

36. World cancer day
World cancer day
Celebrated when?
What is the theme for the year ?
• Breast cancer awareness month

37. SCORES

38. Round 4-Teer na sahi tukka hi sahi
• No negative marking !!!
• True /False
• +5/0

39. DCIS
1. 2 mm margin is considered adequate.
2. Modified VNPI added age as a new criteria
3. Lumpectomy and lymph node surgery
followed by WBRT is the std of care
4. Cribriform pattern is associated with good
prognosis
5 According to EORTC 10853 Age <45 yrs is
associated with significantly increased local
recurrence.

40. Male breast cancer
1. Average age of presentation is earlier than
female counter part
2. Undescended testes is a risk factor
3. BRCA2 > BRCA1
4. Lobular histology is uncommon
5. Associated with high rates of hormone
expression receptors

41. Mammaprint
1. It is a 70 gene assay
2. No intermediate risk category
3. It is irrespective of ER or Her-2 Status
4. It can be performed in patients with 3 nodes
positive
5. Medullary histology is an exclusion criteria

42. Identify the person

43. What is the relation

44. Tie breaker

46. Where are these statues found ?

49. Tie breakers
• Tell the VNPI score
• Tell the Stage grouping
• Tell the allred score

50. Bone

51. • Name the Non-steroidal Aromatase inhibitor ?
1. Anastrozole
2. Tamoxifen
3. Exemestein
4. Fulvestrant

52. Danish 82c trial, all are true except
1. Patients were postmenopausal
2. Tamoxifen was given for 5 years
3. LRR were decreased in RT+ tamoxifen arm
4. Around 10% benefit in OS with addition of
PMRT

53. Audience Q

54. Breast cancer in pregnancy
• ALND is mandatory
• MRM is the std of care
• Trastuzumab can be used safely
• Termination of pregnancy improves the
survival
• Breast feeding is contraindicated
• Chemotherapy should be given is last trimester
3-4 weeks prior to delivery

55. • In early her-2 + ca no benefit of extension of
Trastuzumab to 2 yrs in comparison to 1 yr